Sign up for our eNewsletters
Get the latest news and updates

Industry News

shutterstock_2413141125
cell culture in a laboratory
The agreement gives WuXi Biologics access to Transcenta’s intensified continuous bioprocessing platform for CMC development and manufacturing programs.
Sept. 11, 2026
The program, which is expected to begin in Q4 2026, will transfer and scale eXoZymes’ N-trans-caffeoyltyramine production process at Curia facilities in Spain and Italy.
Sept. 11, 2026
The agreement extends commitments through 2033, with production to take place at Samsung Biologics’ Songdo site in South Korea.
Sept. 10, 2026
The global CDMO’s Bend facility will add two PSD-4 spray-drying units, with operations expected to begin in 2029 and more than 80 jobs created.
Sept. 10, 2026

Learning Resources

Sponsored
Explore a more connected approach to equipment events, compliance workflows, and cross-system coordination.
Sept. 9, 2026
Sponsored
This webinar will highlight green practices, waste reduction efforts, water conservation, evolving regulations, and emerging trends as the industry looks to mitigate its environmental...
Sept. 24, 2026
dreamstime_xxl_446247687
dreamstime_xxl_446247687
Sponsored
The pharmaceutical packaging market is poised for robust growth, fueled by the demand for safe, convenient, and sustainable solutions. Smart and active packaging technologies ...
Aug. 25, 2026
Sponsored
Learn how oxygen-enriched biological treatment helps pharmaceutical manufacturers unlock up to 50% additional wastewater treatment capacity, improve oxygen transfer efficiency...
Aug. 7, 2026

Podcast

Editors' (re)View

Scheduled to tour the company’s flagship “smart factory” in Bridgewater this week, it was called off after losing Bristol Myers Squibb as a customer.
Aug. 26, 2026
Branded a “Chinese military” company by the Department of Defense, the CRDMO secured a legal victory last week against the 1260H designation, but the damage is done.
Aug. 11, 2026
Proponents say using fermentation processes can help reduce America’s reliance on China and India for key starting materials and active pharmaceutical ingredients.
Aug. 7, 2026
While generic pharmaceutical products made outside the U.S. remain tariff-free for the time being, the rate could be raised to as much as a 200% duty.
July 24, 2026

Production

Five teams will create automated platforms capable of producing RNA-based genetic medicines and performing quality control testing at or near the point of care.
Sept. 2, 2026
Bioreactor automation and control systems grow to 38.6% adoption or planned implementation, finds 2026 annual report and survey by BioPlan Associates.
Aug. 31, 2026
Manufacturers are expanding capacity while adopting automation, isolator technology, and new workforce strategies to meet increasing demands.
Aug. 6, 2026
Non-contact cleaning is often preferred to reduce the potential for cross contamination by removing loose fibers and dust.
July 30, 2026

Development

As pipelines expand and technical challenges mount, sponsors are increasingly relying on outsourcing partners well before commercialization.
Aug. 19, 2026
The integration of chemical engineering into process development has transformed how companies scale, control, and optimize manufacturing for a new generation of therapies.
June 25, 2026
The draft guidance allows developers to leverage chemistry, manufacturing and controls data, as well as nonclinical and clinical information from ⁠other relevant products.
June 3, 2026
As regulatory support grows for botanical therapies, developers face the complex task of standardizing nature for pharmaceutical production.
May 8, 2026

Information Technology

Sponsored
AI is helping life sciences manufacturers improve uptime, PM effectiveness, calibration planning, and reliability analysis. See where practical AI adds value in GMP asset management...
April 15, 2026
Software platforms can seamlessly integrate with emerging technologies to unlock efficiencies, strengthen sustainability and enable proactive prevention of disruptions.
Sept. 10, 2025
To prioritize data integrity in the lab, companies must implement good data practices throughout the R&D process
June 24, 2024
Built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing
May 2, 2024

Compliance

The CRL relates to Good Manufacturing Practice observations at third-party manufacturer NerPharMa, and a request for additional commercial-scale consecutive batch data.
Aug. 20, 2026
In response, Scholar Rock will remove the Bloomington fill-finish facility from its Biologics License Application with the agency and rely on a third-party provider.
Aug. 10, 2026
As one of seven companies picked for the pilot, the integrated development and manufacturing organization says regulatory engagement cuts commercialization risk.
July 9, 2026
The agency selected contract manufacturers Cellares and Fujifilm Biotechnologies, as well as Big Pharma drugmakers Eli Lilly and Regeneron, for the pilot’s initial cohort.
June 30, 2026

Quality & Risk

The drugmakers pledged to invest $19.6 billion collectively in U.S. manufacturing and provide discounts on select medicines in exchange for tariff exemptions.
Sept. 1, 2026
Germany is at the greatest commercial risk from Washington’s onshoring policies that may trigger tariff and non-tariff measures, warns the data and analytics firm.
Aug. 18, 2026
The agency wants to increase the fee starting in fiscal 2028 for all foreign API, finished dosage form, and contract manufacturing organization facilities.
Aug. 13, 2026
The CDMO’s new platform reflects a broader shift toward using artificial intelligence to help teams manage increasingly complex manufacturing data.
Aug. 12, 2026